Eli Lilly Launches Foundayo: UK First to Get Oral Obesity Pill
Eli Lilly has officially launched its oral weight-loss and Type 2 diabetes medication, Foundayo—known scientifically as orforglipron—in the United Kingdom, marking a major milestone in the global effort to combat metabolic health crises. The UK is the first country in Europe to receive the drug, signaling a significant shift in pharmaceutical strategy as the company…